Last $0.0004 USD
Change Today -0.0001 / -20.00%
Volume 1.0K
CURXQ On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

curaxis pharmaceutical corp (CURXQ) Snapshot

Open
$0.0004
Previous Close
$0.0005
Day High
$0.0004
Day Low
$0.0004
52 Week High
02/27/14 - $0.02
52 Week Low
11/20/13 - $0.0004
Market Cap
33.4K
Average Volume 10 Days
27.7K
EPS TTM
--
Shares Outstanding
83.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CURAXIS PHARMACEUTICAL CORP (CURXQ)

Related News

No related news articles were found.

curaxis pharmaceutical corp (CURXQ) Related Businessweek News

No Related Businessweek News Found

curaxis pharmaceutical corp (CURXQ) Details

Curaxis Pharmaceutical Corporation, a development stage specialty pharmaceutical company, focuses on developing a hormone drug product candidate for the treatment of Alzheimer’s disease and multiple cancers. Its therapeutic platform is based on the hypothesis that various diseases of aging might be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis, a hormonal endocrine feedback loop that controls development, reproduction, and aging in animals. The company’s clinical programs include ALADDIN I, which completed Phase II clinical trial to evaluate leuprolide acetate for the treatment of women aged 65 years or older with mild to moderate Alzheimer’s disease; ALADDIN II, which completed Phase II clinical trial to evaluate leuprolide acetate for the treatment of men aged 65 years or older with mild to moderate Alzheimer’s disease; and ALADDIN 105 that completed Phase I clinical trial to determine the safety and tolerability of VP4896 implants at various dose combinations on healthy post-menopausal women aged 45 to 70 years and men aged between 50 to 70 years. Curaxis Pharmaceutical Corporation was founded in 2001 and is based in Raleigh, North Carolina. On July 30, 2012, Curaxis Pharmaceutical Corp. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.

2 Employees
Last Reported Date: 03/29/12
Founded in 2001

curaxis pharmaceutical corp (CURXQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CURXQ:US $0.00 USD -0.0001

CURXQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CURXQ.
View Industry Companies
 

Industry Analysis

CURXQ

Industry Average

Valuation CURXQ Industry Range
No financial data is available for CURXQ.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURAXIS PHARMACEUTICAL CORP, please visit www.curaxispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.